BHIC — BioScience Health Innovations, Inc.

—
OTC · Information Technology · IT Services · CIK 1784440 ·
Last close
$5.00
Market Cap
$58.76M
52W High
$9.98
52W Low
$1.59
ADV30
775
Next earnings
—
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,036,364 659,483 -217,882 -185,753 2,136,150 712,378 301,209
Mar 2026 750,946 485,596 -229,907 -229,907 2,330,239 1,145,005 645,749
Dec 2025 1,572,757 571,863 -156,669 -233,630 1,707,181 661,925 229,851
Jun 2025 1,757,463 1,074,478 457,704 457,704 2,057,374 1,299,407 337,632

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-909,667
Investing CF
$-53,808
Financing CF
$807,495
CapEx
$-56,850
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.04
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-114,653
Inventory
$797,183
Receivables
$431,891
ST Investments
—
EBIT TTM
$-146,754
Pretax Income TTM
$-146,754
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,491,494
EBITDA
—
Free Cash Flow
$-1,258,676
Enterprise Value
$82,519,480
Total Cash
$712,378
Total Debt
$260,402
Shares Out
11,752,329
Trailing EPS
$-0.06
Book Value
$0.14
ROE
-37.0%
ROA
-18.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 5,688,717 719,051 642,090 1,707,181 229,851 1,477,330 172,178
Dec 2024 1,844,966 87,000 87,000 873,788 38,548 835,240 23,188
Dec 2023 597,595 -251,500 -251,500 93,388 100,148 -6,760 -307,842
Dec 2022 69,343 -170,450 -170,450 31,608 48,791 -17,183 -182,779

TTM Snapshot

Revenues TTM
$4,491,494
NetIncome TTM
$-658,072
OpCashFlow TTM
—
Assets (Latest)
$2,136,150
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
DTCX Datacentrex, Inc. $58.38M $1.24 —
VIVO VivoPower PLC $59.83M $1.87 —
LGCL Lucas GC Ltd $59.91M $1.40 —
WYY WIDEPOINT CORP $56.10M $5.60 —
PODC PodcastOne, Inc. $62.32M $2.06 —

News headlines (Yahoo Finance, 1h cache)

BioScience Health Innovations, Inc. Announces Its Subsidiary Vitalcore Research has Executed Master Distribution Agreement with Rule Imports
2026-11-06 11:00 · Yahoo
BioScience Health Innovations Announces Two Key Developments Supporting Diversified Growth and Expansion Strategy
2026-11-06 04:05 · Yahoo
Rebelution Partners with Best 365 Labs and Growvana to Scale Science-Backed Cellular Health on Amazon and Beyond
2026-03-12 12:22 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.